BigTime Penny Stocks: OTC's to Watch: Week of 8/14/23 (BDPT, ATGN, EPAZ, GEVI, EVVL)
August 14, 2023 at 02:45 am EDT
Share
The OTC Market's sluggish activity during the summer has become a topic of discussion in various chatrooms and social media forums. However, as summer comes to a close and traders re-engage to seek opportunities, there are numerous potential options awaiting discovery in this market. Recently, we've observed positive trends in specific stocks that we'd like to delve into within this article. So, let's examine and break them down!
Bioadaptives, Inc. (OTC Pink: BDPT) is primarily engaged in researching, marketing, and distributing natural products and medical devices derived from plants, algae, and mushrooms. These products aim to enhance health and well-being in both humans and animals. The company's focus includes natural pain relief, anti-viral, anti-inflammatory, and anti-aging properties. In their latest quarterly report on August 11th, 2023, Bioadaptives revealed that their offering, filed last November, has been fully subscribed. This funding is enabling the company to advance research on their key products, such as Pluripain, SleepEZ, and Primilungs. Additionally, Bioadaptives is exploring expansion on the Amazon marketplace and planning a social media campaign this quarter. We eagerly anticipate further updates from the company through press releases, maintaining a close watch.
Altigen Communications, Inc. (OTCQB: ATGN), headquartered in Silicon Valley, is a prominent provider of Microsoft Cloud Communication Solutions. Their offerings include managed Customer Experience solutions based on the Microsoft platform, incorporating AI technologies to streamline customer engagement and provide insights across the customer journey. In a recent June announcement, the company forged a business partnership to deliver Microsoft Teams Phone Migration Services. This partnership utilizes MIT's UCentric platform to gather crucial user and configuration data from major Voice manufacturers, facilitating a seamless migration to the Teams Phone system. We'll be attentive to forthcoming updates from this company.
Epazz, Inc. (OTC Pink: EPAZ) specializes in tailoring cloud applications for corporations, educational institutions, and the public sector. Their expertise extends to metaverse solutions, blockchain cryptocurrency, mobile apps, and cloud-based software. Notably, the company's ZenaDrone secured funding to enter the oil and gas industry in Houston, Texas. Discussions with major oil companies revolve around employing these drones for inspections and parts delivery to refineries and offshore oil facilities. The company's CEO, Shaun Passley, expressed confidence in revenue generation through this endeavor. The company is also active on social media, promising further updates for the upcoming week.
General Enterprise Ventures Inc. (OTC Pink: GEVI) focuses on developing innovative technologies to address real-world challenges. Their acquisition of Mighty Fire Breaker LLC in 2022 brought them 19 patents centered around wildfire prevention technology. Notably, their Citrotech MFB 31 Technology demonstrated its ability to halt wildfire advancement, garnering attention from media outlets like ABC7 TV's "Eyewitness News." This innovation could potentially reduce insurance premiums for at-risk properties. With recent news of insurance companies curtailing coverage for California properties, GEVI's technology could play a pivotal role. The company's stock approached 52-week highs recently, prompting continued monitoring.
Evil Empire Designs Inc. (OTC Pink: EVVL) is dedicated to designing top-quality aftermarket parts for motorcycle enthusiasts, targeting those with American, V-Twin, Metric, or Harley motorcycles. Their goal is to enable individuals to express their uniqueness through enhanced motorcycle aesthetics. A significant development occurred as Evil Empire Designs entered into a share exchange agreement with Trendmark Industries, Inc. This agreement grants Evil Empire Designs ownership of Trendmark, including its manufacturing capabilities, molds, inventory, equipment, and compatible intellectual property. With an almost reaching of 52-week highs and a limited float, the company remains under observation.
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. We have been retained by a third party, Cambridge Consulting, to assist in the production and distribution of content. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTime Penny is not a fiduciary by virtue of any person's use of or access to this content.
BioAdaptives, Inc. manufactures and distributes natural plant and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress; endurance; recovery from injury, illness, and exercise; and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. Its product line for humans includes PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore. It also markets the Lung Flute and PrimiLungs products in its Lung Armor packaging, emphasizing the anti-viral properties of the nutraceutical and general respiratory health benefits from use of the device. Its animal products include an Equine All-in-One and Equine All-In-One Plus formulation, which it markets to trainers, horse owners and boarding stables, and a Canine All-in-One.
BIOADAPTIVES, INC. 